NEW DRUGS FOR OSTEOPOROSIS THERAPY: A REVIEW OF THE CLINICAL TRIALS PHASE 2 AND 3
Journal Title: Acta Facultatis Medicae Naissensis - Year 2014, Vol 31, Issue 1
Abstract
Osteoporosis is a chronic disease with increasing incidence that predominantly occurs in female population. There are evidences that bisphosphonates, selective estrogen receptor modulators, denosumab, teriparatide and strontium renalate, prevent vertebral fractures while alendronate, risedronate, zoledronic acid, denosumab and strontium renalate prevent hip fractures. Although these drugs are effective in osteoporosis treatment, their use is limited by their side-effects and low-adherence. The aim of this review article was to compare efficacy of new drugs for osteoporosis currently in phase 2 and 3 clinical trials. After reviewing 57 articles available on PubMed and Scopus databases that evaluated efficacy of osteoporosis medications, 10 papers, that fulfilled the review criteria, were selected for the analysis. Finally, the efficacy of five drugs was compared. Efficacy was evaluated by the values of bone mineral density (BMD) and bone turnover markers (BTM). In all the analyzed articles the BMD increased and changes of BTM were noted. The highest increase of lumbar BMD from the baseline values was achieved after six months of subcutaneous application of 20 μg/day teriparatide (11.3%). The lowest increase of BMD in the same region was recorded after six months of risedronate therapy 100 mg per os once monthly (2.1%). From ten selected articles, only one has reported data about fracture risk.
Authors and Affiliations
Ivana Tadić, Ljiljana Tasić, Nada Vujašinović Stupar, Katarina Ilić, Dejan Stevanović
ОSVRT NA ЕKОNОMSKU ЕVАLUАCIЈU ZDRАVSTVЕNЕ ZАŠTITЕ
Polazeći od redukovane definicije zdravlja, u smislu odsustva bolesti i invalidnosti, u radu se objašnjava primenljivost tri kardinalna načela ekonomske nauke (oskudnost resursa i imperativ izbora, oportunitetni troškovi...
TRANSPLANTACIJA UMBILIKALNIH MATIČNIH ĆELIJA HEMATOPOEZE KOD ODRASLIH BOLESNIKA SA MALIGNIM HEMOPATIJAMA
Transplantacija matičnih ćelija hematopoeze iz umbilikalne krvi se u proteklim godinama pokazala kao uspešna alternativna metoda lečenja odraslih bolesnika sa malignim i nemalignim hematološkim bolestima, koji nisu imali...
Biomarkeri stresa u pljuvački
Stres se definiše kao stanje u kome je homeostaza, kao dinamička ravnoteža unutrašnjih uslova neophodnih za pravilno funkcionisanje ćelija ili živog organizma u cjelini, ugrožena djelovanjem različitih stresora. St...
LYMPHOCYTE SUBSETS IN BRONCHOALVEOLAR LAVAGE FLUID OF CHILDREN WITH LUNG INFILTRATES
The analysis of the subpopulation of lymphocytes - CD4+, CD8+ lymphocytes in bronchoalveolar lavage (BAL) of paediatric patients can provide useful information related the lung parenchyma. The aim of the paper was to ana...
CEREBRAL CAVERNOUS MALFORMATIONS: NEW INSIGHT IN MECHANISMS OF DISEASE
Cerebral cavernous malformations (CCMs) are the most common vascular malformations in the brain, and occur at a rate of approximately 0.6 per 100.000 people. Recognized as familial or sporadic cases, CCMs are characteriz...